[1] ZHOU C Y, LI G, LI Y C, et al. A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats[J]. Mol Biosyst, 2015, 11(2):418-433.
[2] FOROUZANFAR M H, ALEXANDER L, ANDERSON H R, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 386(10010):2287-2323.
[3] MAO J F, XIA Z F, CHEN J N, et al. Prevalence and risk factors for canine obesity surveyed in veterinary practices in Beijing, China[J]. Prev Vet Med, 2013, 112(3-4):438-442.
[4] CORBEE R J. Obesity in show cats[J]. J Anim Physiol Anim Nutr, 2014, 98(6):1075-1080.
[5] MOGHADASIAN M H, FROHLICH J J, MCMANUS B M. Advances in experimental dyslipidemia and atherosclerosis[J]. Lab Invest, 2001, 81(9):1173-1183.
[6] ROSINI T C, SILVA A S R D, MORAES C D. Diet-induced obesity:rodent model for the study of obesity-related disorders[J]. Rev Assoc Med Bras, 2012, 58(3):383-387.
[7] WU Q, ZHANG H, DONG X, et al. UPLC-Q-TOF/MS based metabolomic profiling of serum and urine of hyperlipidemic rats induced by high fat diet[J]. J Pharm Anal, 2014, 4(6):360-367.
[8] MIAO H, CHEN H, PEI S W, et al. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia[J]. Chem Biol Interact, 2015, 228:79-87.
[9] TANG C H, ZHANG K, ZHAO Q Y, et al. Effects of dietary genistein on plasma and liver lipids, hepatic gene expression, and plasma metabolic profiles of hamsters with diet-induced hyperlipidemia[J]. J Agric Food Chem, 2015, 63(36):7929-7936.
[10] 满都日娃, 马利芹, 利凯, 等. 犬、猫肥胖症的防止[J]. 河北北方学院学报:自然科学版, 2009, 25(3):58-59, 63.
MAN D R W, MA L Q, LI K, et al. Prevention of obesity in pet dog and cats[J]. Journal of Hebei North University:Natural Science Edition, 2009, 25(3):58-59, 63. (in Chinese)
[11] 叶妍琳, 白正广, 张斌恺, 等. 犬、猫肥胖症病因分析及管理[J]. 上海畜牧兽医通讯, 2015(1):62-63.
YE Y L, BAI Z G, ZHANG B K, et al. Analysis and management of obesity in dog and cat[J]. Shanghai Journal of Animal Husbandry and Veterinary Medicine, 2015(1):62-63. (in Chinese)
[12] XU S W, LIU Z P, LIU P Q. HDL cholesterol in cardiovascular diseases:the good, the bad, and the ugly[J]. Int J Cardiol, 2013, 168(4):3157-3159.
[13] WANG Z, LI P, WANG C J, et al. Protective effects of Arctium lappa L. root extracts (AREs) on high fat diet induced quail atherosclerosis[J]. BMC Complement Altern Med, 2016, 16:6.
[14] 罗朵生, 李坤平, 朴胜华, 等. 高脂血症大鼠造模过程中血液代谢组学研究[J]. 中药新药与临床药理, 2016, 27(1):70-74.
LUO D S, LI K P, PIAO S H, et al. Study of blood metabonomics in rat hyperlipidemia model[J]. Traditional Chinese Drug Research & Clinical Pharmacology, 2016, 27(1):70-74. (in Chinese)
[15] 周云枫, 李沙, 苏文, 等. 不同脂肪含量的高脂纯化配方饲料对大、小鼠代谢综合征发生的影响[J]. 基础医学与临床, 2012, 32(3):273-277.
ZHOU Y F, LI S, SU W, et al. Effect of diets with different fat content on metabolic syndrome of rats and mice[J]. Basic & Clinical Medicine, 2012, 32(3):273-277. (in Chinese)
[16] YAO W F, GU H W, ZHU J J, et al. Integrated plasma and urine metabolomics coupled with HPLC/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan[J]. Anal Bioanal Chem, 2014, 406(28):7367-7378.
[17] 陈眷华, 卢占军, 徐在品, 等. 大黄醇提液抗家兔实验性动脉粥样硬化作用的病理形态学研究[J]. 畜牧兽医学报, 2007, 38(7):728-734.
CHEN J H, LU Z J, XU Z P, et al. Pathological study on anti-experimental atherosclerotic effects of rhubarb ethanol-extract in rabbits[J]. Acta Veterinaria et Zootechnica Sinica, 2007, 38(7):728-734. (in Chinese)
[18] 孟良艳, 陈秀琴, 石达友, 等. 四君子汤对脾虚大鼠肠道菌群多样性的影响[J]. 畜牧兽医学报, 2013, 44(12):2029-2035.
MENG L Y, CHEN X Q, SHI D Y, et al. Influence of Sijunzi decoction on intestinal flora diversity in spleen-deficient rat[J]. Acta Veterinaria et Zootechnica Sinica, 2013, 44(12):2029-2035. (in Chinese)
[19] ZHAO L P. The gut microbiota and obesity:from correlation to causality[J]. Nat Rev Microbiol, 2013, 11(9):639-647.
[20] CHENG M, QIAN L T, SHEN G D, et al. Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism[J]. Cancer Res, 2014, 74(15):4030-4041.
[21] HUANG Y E, WANG Y, HE Y, et al. Homogeneity of the vaginal microbiome at the cervix, posterior fornix, and vaginal canal in pregnant Chinese women[J]. Microb Ecol, 2015, 69(2):407-414.
[22] 黄红丽, 周永健, 郑啼婴, 等. 肠道菌群在非酒精性脂肪性肝病大鼠中的变化及意义[J]. 广东医学, 2016, 37(9):1283-1286.
HUANG H L, ZHOU Y J, ZHENG T Y, et al. Changes of intestinal flora in rats with non-alcoholic fatty liver disease and its significance[J]. Guangdong Medical Journal, 2016, 37(9):1283-1286. (in Chinese)
[23] LE CHATELIER E, NIELSEN T, QIN J J, et al. Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500(7464):541-546.
[24] 朱超霞, 仓桢, 加孜热亚·再依拿提, 等. 盐酸小檗碱对高脂饮食诱导的非酒精性脂肪性肝病大鼠肠道菌群的影响[J]. 上海交通大学学报:医学版, 2015, 35(4):483-488.
ZHU C X, CANG Z, JIAZIREYA Z, et al. Effects of berberine on gut microbiota of rats with non-alcoholic fatty liver disease induced by high-fat diet[J]. Journal of Shanghai Jiao Tong University:Medical Science, 2015, 35(4):483-488. (in Chinese)
[25] CHEN D W, YANG Z Q, CHEN X, et al. Effect of lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet[J]. J Microbiol Biotechnol, 2015, 25(5):687-695.
[26] YIN X C, PENG J H, ZHAO L P, et al. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula[J]. Syst Appl Microbiol, 2013, 36(3):188-196.
[27] PANASEVICH M R, MORRIS E M, CHINTAPALLI S V, et al. Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet[J]. Am J Physiol Gastrointest Liver Physiol, 2016, 311(1):G166-G179. |